| Abigail L Allen, PA-C | |
|
730 W Market St, Lima, OH 45801-4602 | |
| (419) 227-3361 | |
| Not Available |
| Full Name | Abigail L Allen |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 730 W Market St, Lima, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801147178 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50-003592 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blanchard Valley Hospital | Findlay, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blanchard Valley Medical Practice Llc | 9234168147 | 68 |
News Archive
Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).
Genetically engineered potatoes offer new hope in the fight against the Hepatitis B Virus (HBV), an acute sometimes fatal form of viral hepatitis caused by a DNA virus that persists in the blood serum and is transmitted by sexual contact or by transfusion or by ingestion of contaminated blood or other bodily fluids.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
Salk Institute scientists showed how an FDA-approved drug boosts the health of brain cells by limiting their energy use. Like removing unnecessary lighting from a financially strapped household to save on electricity bills, the drug-called rapamycin-prolongs the survival of diseased neurons by forcing them to reduce protein production to conserve cellular energy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abigail L Allen, PA-C 4750 Hempstead Station Dr, Kettering, OH 45429-5164 Ph: (800) 875-0136 | Abigail L Allen, PA-C 730 W Market St, Lima, OH 45801-4602 Ph: (419) 227-3361 |
News Archive
Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).
Genetically engineered potatoes offer new hope in the fight against the Hepatitis B Virus (HBV), an acute sometimes fatal form of viral hepatitis caused by a DNA virus that persists in the blood serum and is transmitted by sexual contact or by transfusion or by ingestion of contaminated blood or other bodily fluids.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
Salk Institute scientists showed how an FDA-approved drug boosts the health of brain cells by limiting their energy use. Like removing unnecessary lighting from a financially strapped household to save on electricity bills, the drug-called rapamycin-prolongs the survival of diseased neurons by forcing them to reduce protein production to conserve cellular energy.
› Verified 8 days ago
Alicia Thornton, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1001 Bellefontaine Ave, Lima, OH 45804 Phone: 419-228-3335 | |
Mrs. Natalie B Coon, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1003 Bellefontaine Ave, Suite 125, Lima, OH 45804 Phone: 419-998-8207 Fax: 419-998-8216 | |
Cameron Everett Pappa, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 830 W High St Ste 360, Lima, OH 45801 Phone: 419-227-7117 Fax: 419-227-2848 | |
Mrs. Sierra N Bielcassarino, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1003 Bellefontaine Ave Ste 150, Lima, OH 45804 Phone: 419-998-8295 Fax: 419-226-8323 | |
Timothy Ohlemacher, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 770 W High St Ste 160, Lima, OH 45801 Phone: 419-996-5224 Fax: 419-996-5276 | |
Lindsey Alexandra Schroeder, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1003 Bellefontaine Ave, Lima, OH 45804 Phone: 419-228-3335 | |
Tanner Stippich, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 Medical Dr Ste A, Lima, OH 45804 Phone: 419-222-6622 Fax: 419-224-0015 |